Showing results (91-100 of 6,181) with videos related to
Sort By:
Pageof 619
Clinical Nephrology|October 15, 2009
Renal AA amyloidosis secondary to morbid obesity?E Alsina, M Martin, Mj Panadés, et al.Clinical Nephrology|September 1, 1990
The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trialR G Walker, S H Yu, J E Owen, et al.Clinical Nephrology|January 20, 2012
Renal actinomycosis with concomitant renal vein thrombosisDong-Suk Chang, Won Ik Jang, Ji Yoon Jung, et al.Clinical Nephrology|January 20, 2012
Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: case report of a patient treated with endothelin receptor antagonistAttilio Losito, Loretta Pittavini, Carla CovarelliClinical Nephrology|March 27, 2012
Rituximab therapy for Type I membranoproliferative glomerulonephritisJohn J Dillon, Michelle Hladunewich, William E Haley, et al.Clinical Nephrology|December 22, 2011
Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind studyMarianne Haag-Weber, Kai-Uwe Eckardt, Walter H Hörl, et al.Clinical Nephrology|December 22, 2011
Clinical characteristics of obstructive uropathy associated with rotavirus gastroenteritis in JapanAkira Ashida, Mikiya Fujieda, Kazuhide Ohta, et al.Clinical Nephrology|December 22, 2011
Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathyJohn M Carson, Eric D Newman, John L Farber, et al.Clinical Nephrology|March 27, 2012
Relation of homocysteine to early nephropathy in patients with Type 2 diabetesJianbo Li, Ming Shi, Hongman Zhang, et al.Clinical Nephrology|March 24, 2011
The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patientsE Zitt, A H Kirsch, M Haueis, et al.Pageof 619